1. Boehringer Ingelheim International Gmbh (13 from 1,536 patents)

1. 11304929 - Tosylacetate based compounds and derivatives thereof as PHGDH inhibitors

2. 11179371 - Triazole benzamide derivatives as GPR142 agonists

3. 10640486 - Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors

4. 10501440 - Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors

5. 10399961 - Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors

6. 9029360 - Pyrazolopyrimidines as metabotropic glutamate 5 receptor antagonists

7. 8883789 - Piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors

8. 8822471 - Compounds, pharmaceutical compositions and uses thereof

9. 8796467 - Compounds

10. 8741892 - Compounds

11. 8716277 - Substituted imidazole compounds useful as positive allosteric modulators of mGlu5 receptor activity

12. 8642774 - Compounds

13. 8637550 - Heteroaryl diamide compounds useful as MMP-13 inhibitors